Adamas to Present at Upcoming SVB Leerink CNS Forum
23 Junio 2021 - 3:42PM
Business Wire
Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated
to developing and delivering medicines that make a meaningful
difference to people affected by neurological diseases, today
announced that the company will present “What’s Happening in
Parkinson’s Disease & the GOCOVRI Opportunity” at the SVB
Leerink CNS Forum on Tuesday, June 29th at 1:10 pm Eastern
Time.
The presentation will be broadcast live from the investor
relations section of the Adamas website at
http://ir.adamaspharma.com/events-presentations. Replays of the
event will be available for 30 days.
About Adamas Pharmaceuticals, Inc.
At Adamas our vision is clear – to deliver innovative medicines
that reduce the burden of neurological diseases on patients,
caregivers and, society. We are a fully-integrated company focused
on growing a portfolio of therapies to address a range of
neurological diseases. For more information, please visit
www.adamaspharma.com.
Source: Adamas Pharmaceuticals, Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210623005941/en/
Media: Sarah Mathieson Vice President, Corporate
Communications 510-450-3528 smathieson@adamaspharma.com
Investors: Peter Vozzo Managing Director Westwicke/ICR
443-213-0505 peter.vozzo@westwicke.com
Adamas Pharmaceuticals (NASDAQ:ADMS)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Adamas Pharmaceuticals (NASDAQ:ADMS)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Adamas Pharmaceuticals Inc (NASDAQ): 0 recent articles
Más de Adamas Pharmaceuticals, Inc. Artículos de Noticias